# A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)

> **NCT07743151** · PHASE1 · RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 400 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MK-1406

## Key facts

- **NCT ID:** NCT07743151
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-10
- **Primary completion:** 2027-02-05
- **Final completion:** 2027-02-05
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743151, "A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07743151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*